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ABSTRACT
Cut-and-paste transposons are important tools for
mutagenesis, gene-delivery and DNA sequencing ap-
plications. At the molecular level, the most thor-
oughly understood are Tn5 and Tn10 in bacteria,
and mariner and hAT elements in eukaryotes. All
bacterial cut-and-paste transposases characterized
to date are monomeric prior to interacting with the
transposon end, while all eukaryotic transposases
are multimers. Although there is a limited sample
size, we proposed that this defines two pathways
for transpososome assembly which distinguishes
the mechanism of the bacterial and eukaryotic trans-
posons. We predicted that the respective pathways
would dictate how the rate of transposition is re-
lated to transposase concentration and genome size.
Here, we have tested these predictions by creat-
ing a single-chain dimer version of the bacterial
Tn5 transposase. We show that artificial dimerization
switches the transpososome assembly pathway from
the bacterial-style to the eukaryotic-style. Although
this had no effect in vitro, where the transposase
does not have to search far to locate the transpo-
son ends, it increased the rate of transposition in
bacterial and HeLa cell assays. However, in contrast
to the mariner elements, the Tn5 single-chain dimer
remained unaffected by over-production inhibition,
which is an emergent property of the transposase
subunit structure in the mariner elements.
INTRODUCTION
DNA transposons are widely distributed in nature and are
an important source of variation (1). Most elements encode
only one, or sometimes two, proteins that are required for
transposition. Bioinformatic and biochemical analyses re-
vealed that there are several families of transposons with
distinctly different molecular mechanisms for mobilization
and amplification. Some of the families, andmodes of trans-
position, have a restricted phylogenetic distribution, while
others are almost universal. The most widely distributed el-
ements are probably those in which the transposase has an
RNaseH-like structural-fold with aDDE(D) triad of amino
acids in the active site. Of these, the cut-and-paste elements
are the most successful, and include many examples such as
Tn10, Tn5 and members of the IS630-Tc1-mariner (ITm)
superfamily (2).
Transposon mutagenesis is a widely used tool in genet-
ics and biochemistry. Sleeping Beauty and piggyBac are the
most efficient in mammalian cells, while Tn10, Tn5 and
phage Mu are often used in bacteria (3,4,5,6). In vitro re-
constituted versions of Tn5 and Mu are particularly use-
ful because the transpososomes can be assembled from pu-
rified components and used to mutagenize DNA in vitro
or delivered into cells by transformation or electroporation
(7,8,9). When used in vitro, these systems are almost 100%
efficient and their applications include the fragmentation of
DNA and the delivery of sequence tags for deep sequenc-
ing library construction. However, attempts at integration
in mammalian cells have provided patchy results. Microin-
jection, electroporation and particle bombardment of Tn5
and bacteriophage Mu transpososomes have been used to
integrate DNA into the genomes of mammalian cells, rice
plants, yeast and trypanosomes (10,11,12,13). However, the
two-plasmid transfection-assay, widely used for Sleeping
Beauty and piggyBac transgenesis, has not been reported
for Tn5. In this type of assay, the reporter-transposon is on
one plasmid, while the transposase expression cassette is on
another (14).
Before the transposon can be excised from the donor site,
the transposasemust first bind both ends of the element and
bring them together in a paired ends complex (PEC), also
sometimes called a synaptic complex or transpososome. In
Tn5 the complex contains twomonomers, which each cleave
both strands of DNA at the respective ends of the transpo-
son (15,16). The requirement for synapsis before catalysis is
presumably an adaptive feature that protects the transpo-
son and the host from the DNA damage that might arise
from a partial-reaction at one end of the element. Assembly
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of the transpososome is also a key checkpoint: all known
regulatory-mechanisms operate before this stage of the re-
action, and after the complex has formed the transposon is
committed to transposition.
Genome size is an important factor that affects the rate
of transposition in eukaryotic cells were transcription and
translation are uncoupled (i.e. take place in different com-
partments). If a transposon has a broad phylogenetic dis-
tribution, the transposase must be able to search for and
find the transposon ends in genomes that range in size over
five orders of magnitude (∼106 - 1011 bp). In the bacte-
rial elements, such as Tn10, Tn5 and IS911, for example,
this difficulty is largely circumvented by a cis-acting trans-
posase; in other words each transposon sees only the trans-
posase transcribed and translated from its own transposase
gene (17,18,19). There are several mechanisms for cis-action
but they all require coupled transcription and translation,
which ensures that the transposase is synthesized close to
the transposon. This means that the apparent transposase-
concentration is largely independent of the genome size and
cellular volume. However, in eukaryotes the transposase
must search for transposon ends after entering the nucleus.
Previously, we investigated this problem in a mariner
transposon using a combination of biochemical analysis
and computer simulations (20,21,22,23,24,25). Biochem-
ical analysis had shown that many bacterial DDE(D)
transposase are monomers and multimerize only after in-
teracting with the transposon ends (e.g. (26,27,28,29)).
In contrast, those eukaryotic members of the super-
family examined to date are multimers in solution (e.g.
(30,31,32,33,34,35)). Our hypothesis was that the multi-
meric state defined two pathways for synaptic-complex as-
sembly (Figure 1A and B). In eukaryotes, the transposase
multimer would first bind one end and then recruit a second
unbound end. We term this synapsis-by-naked-end-capture
(S-NEC) (22). In many bacterial elements, the monomeric
transposase interacts independently with the transposon
ends and the transpososome is assembled by a mechanism
that we term synapsis by protein dimerization (S-PD) (22).
This is intrinsically less efficient because two transposase
monomers and two transposon ends must interact simulta-
neously (Figure 1B). A computer simulation demonstrated
that an S-NEC reaction is faster than S-PD at any given
transposase concentration (Figure 1C). We went on to in-
corporate autoregulation into the simulations to get in-
sight into the ways in which the exponential amplification
of transposons can be suppressed (22). One of the insights
was the way in which the rate of transposition responds to
genome size (Figure 1D and E). In an S-PD reaction the
rate decreases with genome size (Figure 1D). In a eukary-
otic system, in the absence of cis-action, this is expected
because transposase is sequestered in non-specific DNA-
interactions and takes longer to locate the transposon ends
and assemble the transpososome. This response might also
be expected in an S-NEC reaction. However, the simula-
tion yielded a counter-intuitive result: above a certain trans-
posase concentration, the rate of transposition increases
with genome size (Figure 1E). This is because non-specific
interactions relieve auto-inhibition of the transposase (22).
The veracity of the S-NEC simulations was supported
by the dose-response curves for the Hsmar1, piggyBac and
Sleeping Beauty transposases in HeLa cells (22). To extend
our experimental tests of the hypothesis and the simula-
tions, we wished to manipulate the subunit architecture of
the transposases. We do not know of any reports of muta-
tions that disrupt the subunit interface of a natural trans-
posase multimer without at the same time inhibiting the ac-
tivity e.g. (36,37). However, we wondered whether we could
engineer a dimeric version of a monomeric bacterial trans-
posase and what effect this would have on the reaction.
MATERIALS AND METHODS
Plasmid construction
Plasmid sequences are provided in Supplementary Table
S1. For protein expression and purification, the hyperac-
tive Tn5 transposase gene described by (28) was cloned in
pTYB2 (NEB) between the NdeI and XmaI sites to yield
pRC2128. The single-chain dimeric transposase was con-
structed by joining two copies of the transposase gene with
a 22 amino acid linker (GPSRGGGSEGGGSEGGSGTS
QL) between the C-terminus of the first monomer and N-
terminus of the second to yield pRC2102. Site directed mu-
tagenesis was used to introduce point mutations into the re-
spective subunits of the single-chain dimer. The active site
DDE to ADEmutations in the N- and C-terminal subunits
of the single-chain dimer were expressed frompRC2143 and
pRC2107, respectively. The G462D dimerization mutations
in the N- and C-terminal subunits of the single-chain dimer
were expressed from pRC2152 and pRC2153, respectively.
The reporter plasmid for the in vitro transposition reactions
was pRC2106. This contained the Tn5 mosaic ends (28)
flanking a Neomycin resistance gene.
The papillation reporter transposons for Hsmar1 was en-
coded on plasmid pRC681. This constructed prior to in-
tegration into the genome at the argE locus by lambda
Red recombination (see below). The Hsmar1 reporter had
a pair of transposon ends flanking a promoterless lacZ and
a kanamycin resistance gene (25,38). The Tn5 reporter was
generated by polymerase chain reaction (PCR), which was
used to add argE homology arms and the Tn5mosaic ends
(28) to the lacZ-kan fragment from pRC681. For the papil-
lation assaywith ampicillin themonomeric and single-chain
dimeric Tn5 transposases were expressed from pRC2117
and pRC2109, respectively, which are derived from pMAL-
C2X (NEB). The transposases were inserted between the
NdeI and SbfI sites. This removes the maltose binding pro-
tein gene and leaves the transposase under the control of the
ptac promoter. The Chloramphenicol resistant plasmids of
themonomeric and dimeric Tn5 transposase were pRC2114
and pRC2113, respectively, which are identical to pRC2117
and pRC2109 except for the addition of a chlorampheni-
col resistance cassette at the SwaI site. The Hsmar1 trans-
posase was expressed from pRC1721, which has the bacte-
rial codon optimized transposase gene cloned between the
NdeI and XbaI sites of pMAL-C2X (NEB). As before, this
removes the maltose binding protein gene and leaves the
transposase under the control of the ptac promoter.
For the HeLa cell assays, Tn5 transposase was codon
optimized for expression in human cells and cloned into
pcDNA3.1 with an SV40 nuclear localization signal (NLS)
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Figure 1. Two pathways for transpososome assembly. (A and B) The two pathways for transpososome assembly are illustrated: blue spheres are trans-
posase subunits; half-rectangles are transposon ends. The flanking DNA is omitted for clarity. In the S-NEC pathway a transposase dimer binds to the
transposon end and recruits a second, unbound, end into the developing transpososome. In the S-PD pathway the transposase subunits bind transposon
ends independently and the ends are brought together by protein dimerization. In Tn10, the archetypal bacterial cut-and-paste transposon, and the closely
related Tn5, the synaptic complex is very stable and its assembly is essentially irreversible. In the crystal structure of the Tn5 post-cleavage intermediate
two thirds of the interface between the two halves of the complex is provided by protein–DNA interactions (40). Tight binding of the transposase and
the transposon ends is therefore established only upon synapsis. PEC, paired-ends complex also sometimes called the transpososome or synaptic complex.
(C–E) Computer simulations of a transposon genomic-invasion were performed as in (22). In part D the simulation includes a cis-acting transposase and
a trans-acting inhibitor. In part E regulation is an emergent property of the S-NEC pathway and no additional components are required.
added to the N-terminus and a poly-histidine tag on the C-
terminus. The monomeric and single-chain dimer versions
were named pRC2148 and pRC2147, respectively. The GFP
control was constructed by PCR amplification of sfGFP,
and cloned it into pQE trisystemHis-Strep 1 (Qiagen) at the
NcoI site and named pRC2116. For the GFP-transposase
localization experiments, sfGFPwas PCR amplified and in-
serted into pRC2148 or pRC2147 at the HpaI site (located
between the SV40 NLS and the transposase), in order to
make pRC2164 and pRC2163, respectively. The transposon
reporter plasmid (pRC2194) encoded a neomycin resistance
marker, driven by EM7 and PGK promoters, flanked by a
pair of Tn5 mosaic ends (28) in an inverted configuration.
The transposon was 2589 bp long.
Escherichia coli strain construction
Papillation reporter strains were derived from RC5095,
which is identical to ER1793 (NEB): Escherichia coli
F- fhuA2 Δ(lacZ)r1 glnV44 e14-(McrA-) trp-31 his-1
rpsL104 xyl-7 mtl-2 metB1 Δ(mcrC-mrr)114::IS10.
The Hsmar1 and Tn5 reporter strains were created by
using PCR to amplify the reporter transposons with
homology arms for lambda red recombineering into the
ArgE locus. The Hsmar1 reporter was amplified directly
from pRC681, which encodes a lacZ’-Kan fragment
flanked by a pair of transposon ends. The sequences of
the homology-arms at either end of the reporters were:
5′-cggatgcggcgcgagcgccttatccggcctacgttttaatgccagca and
5′-gcttcaagaaactgcggcgctaaatcgtggctaacttcatgggcggt. The
Tn5 reporter was amplified from the same template except
that the Hsmar1 transposon ends were replaced by a pair
of Tn5 mosaic ends.
Tn5 transposase expression and purification
The Tn5 transposase expression plasmids were transformed
into ER2566 (NEB: F− fhuA2 [lon] ompT lacZ::T7
genel gal sulA11 delta(mcrC-mrr)114::IS10R(mcr-
73::miniTn10)2 R(zgb-210::Tn10)1 (Tetsensitive) endA1
[dcm]). A colony was grown in 20 ml LB supplemented
with 100 g/ml ampicillin at 37◦C for 16 h, before be-
ing used to inoculate 2 l of LB supplemented with 100
g/ml ampicillin. Cells were grown at 37◦C to OD600
= 0.4, whereupon it was made 0.5 mM in isopropyl
-D-1-thiogalactopyranoside (IPTG) and the temperature
adjusted to 23◦C for 4 h. The cells were then centrifuged,
5000 × g at 4◦C for 20 min. The cell pellet was resuspended
in 40 ml column buffer (20 mMTris pH 7.5, 700 mMNaCl,
0.1% Triton X-100, 10% glycerol) and frozen at −80◦C.
The cells were thawed and a protease inhibitor cocktail
tablet (Roche Applied Science) was added. The cells were
lysed using a French Pressure cell (American Instrument
Co., Inc., Silver Spring, MD, USA) at 10 000 Psi. The
lysate was centrifuged at 12 000 × g at 4◦C for 1 h. The
supernatant was loaded onto a column containing 2 ml
of chitin resin (NEB). The resin was washed with 30 ml
column buffer, followed by 6 ml cleavage buffer (column
buffer + 50 mM dithiothreitol [DTT]). The column was
then capped and loaded with 1 ml cleavage buffer, before
being stored for 16 h at 4◦C. Ten 0.5 ml aliquots of the elu-
ate were collected and analyzed on a 10% sodium dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
gel. Transposase was quantified through a Bradford assay.
The samples were then aliquoted and frozen at −80◦C.
In vitro transposition assay
The transposition reaction buffer contained 100mMpotas-
sium glutamate, 0.5 g/ml bovine serum albumin (BSA),
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25 mM Tris.HCl pH 7.5, 0.5 M -mercaptoethanol, 10
mM MgCl2. Reactions (20 l) contained 400 ng (7 nM) of
pRC2106, which encodes two 19 bp Tn5 mosaic ends (28)
flanking a kanamycin resistance gene. The transposase was
added last and was 100 nM unless stated otherwise. Reac-
tions were incubated at 37◦C for 4 h unless stated other-
wise, and were terminated by addition of SDS to 0.2% SDS
and heating to 68◦C for 5 min. Reactions were analyzed on
a 1% agarose Tris/Borate/Ethylenediaminetetraacetic acid
(TBE) buffered gel, which was electrophoresed overnight at
2.3 V/cm. The gel was then stained with ethidium bromide
and photographed.
Electrophoretic mobility shift assay (EMSA)
The electrophoretic mobility shift assay (EMSA) was per-
formed essentially as described previously (25). The binding
buffer contained 100 mM potassium glutamate, 0.5 g/ml
BSA, 25 mM Tris.HCl pH 7.5, 0.5 M -mercaptoethanol.
Each reaction (20 l) contained 2 nM transposon end frag-
ment and 100 nM transposase. DNA fragments encoding
the Tn5 mosaic end were generated by digesting pRC916
with BamHI and XbaI (93 bp), or NotI and KpnI (154 bp)
(39). Fragments were end-labeled with -32P dCTP and the
Klenow enzyme, purified on an 8%TBE polyacrylamide gel
and recovered by the crush and soak method. Transposo-
some complexes were assembled for 15 min at room tem-
perature before addition of 4.5 l 80% glycerol to aid gel
loading on an 8% TBE polyacrylamide gel, which was elec-
trophoresed at 120 V and imaged using a Fuji FLA-3000
phosphorimager. To analyze cleavage, the reactions were
supplemented with 10 mMMgCl2 and incubated for a fur-
ther 2 h at 37◦C.
Papillation assay
The papillation reporter strains for Tn5 and Hsmar1 were
E. coli RC5123 and RC5096, respectively. Cells were trans-
formed with 1 ng of transposase expression plasmid. Cells
were heat shocked at 42◦C, supplemented with 1 ml of LB
and incubated at 37◦C for an hour. For those expression
plasmids that encode ampicillin resistance, the antibiotic
was added to a final concentration of 100 g/ml, after
which the cells were incubated for a further 4 h at 37◦C.Cells
were then serially diluted to 10−4-fold with LB and 100 l
was spread on LB agar plates containing 100 g/ml ampi-
cillin, 0.1% lactose, 40 g/ml X-gal and galactose and/or
IPTG where indicated. For those expression plasmids that
encoded resistance to chloramphenicol, the heat shock and
1 h incubation was the same. After the 1 h incubation 100
l of cells was spread on the LB agar plates containing 25
g/ml chloramphenicol 0.1% lactose, 40 g/ml X-gal and
galactose and/or IPTG where indicated.
Western blotting
Cells were lysed using RIPA buffer (50 mM Tris pH 7.5,
150 mM NaCl, 1 mM Na2-EDTA, 1% Triton X-100, 0.5%
sodium deoxycholate and 0.1% SDS) and 40 l protease
inhibitor cocktail (Roche Applied Science, one tablet dis-
solved in 1 ml water). Samples containing 30 g of pro-
tein were mixed with 4× SDS loading buffer (200 mM
Tris.HCl pH 6.8, 400 mM DTT, 8% SDS, 0.4% bromophe-
nol blue, 40% glycerol) and incubated in a boiling water
bath for 5 min before being loaded on 10% SDS-PAGE gels.
After electrophoresis the gel electroblotted to polyvinyli-
dene fluoride (PVDF) membrane. The membrane was in-
cubated in TBST (50 mM Tris, pH 7.6, 150 mM NaCl,
0.1% Tween® 20) + 5% nonfat dry milk for at least 1 h
at 4◦C. The membrane was incubated with 1 ml of pri-
mary antibody (Serotec anti-6× histidine tag mouse mon-
oclonal) diluted 1000-fold in TBSTM (TBST + 5% nonfat
dry milk) for 1 h at 4◦C. It was then washed three times
with TBSTM and incubated with 1 ml secondary antibody
(Dako polyclonal HPR-conjugated rabbit anti-mouse di-
luted 2000-fold in TBSTM). Themembrane was then devel-
oped using the Promega ECL Chemiluminescence kit and
imaged using the Fujifilm LAS-3000 imaging system.
HeLa cell transfection and integration assay
Cells were seeded into 6-well plates (9 cm2 per well) in Dul-
becco’s modified Eagle’s medium (DMEM) buffer (Sigma-
Aldrich) + 10% FBS (fetal bovine serum), penicillin (100
units per ml) and streptomycin (100 g/ml). The cells were
grown to 70–80% confluence at 37◦C in 5% CO2 atmo-
sphere. Cells were then drained and provided with 3 ml of
DMEM media + 10% FBS without penicillin or strepto-
mycin. Cells were transfected with up to 2 g of plasmid
DNA using Lipofectamine 2000 (Invitrogen), according to
the manufacturer’s instructions.
For the transposon integration assay, HeLa cells were
transfected with 1 g of a transposon reporter plas-
mid (pRC2194) plus 1 g of the transposase expression
plasmid (pRC2147 or pRC2148). After 24 h the cells
were resuspended by trypsin/ethylenediaminetetraacetic
acid (EDTA) treatment and counted using a Hawksley-
Neubauer chamber. Plates (100 mm2) were seeded with 4
× 105 cells in 10 ml media supplemented with 800 g/ml
G418. This media was changed every 3 days for 2 weeks to
allow selection for neomycin resistance. The cells were then
fixed to the plates by treating with 10 ml of 10% formalde-
hyde in PBS, for 15 min. Cell foci were then stained with 10
ml of 1% methylene blue in 70% ethanol for 30 min. Plates
were then washed with water, air-dried and photographed.
For analysis of transposon insertion sites, genomic DNA
was collected from all the remaining foci in the assay and
insertions were mapped using splinkerette or inverse PCR
mapping.
Fluorescence microscopy
The cells were transfectedwith 1g ofGFP-transposase ex-
pression plasmid as described above. After 24 h, the live cells
were imaged, in the 6-well plate, using a Carl Zeiss Axiovert
S100 TV Inverted Microscope with an HBO 100 illumina-
tor.
RESULTS
A Tn5 transposase single-chain dimer
To promote the self-association of Tn5 transposase
monomer we designed a single-chain dimer (Figure 2A).
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Figure 2. Activity of a Tn5 transposase single-chain dimer. (A) The arrangement of the coding regions and the linker in the expression vectors for the
monomeric and dimeric versions of the transposase are illustrated. (B) Concentration titrations and kinetic analyses of the monomeric and dimeric versions
of the transposase. Transposition reactions contained 400 ng (7 nM) of plasmid substrate and 100 nM transposase unless stated otherwise. Photographs
of ethidium bromide stained agarose gels are shown. An Illustration of the substrate and products are provided in Supplementary Figure S2.
It is based on a hyperactive transposase with three point
mutations: one eliminates an alternative start codon, one
increases the affinity for the transposon end and the third
makes the protein trans-acting by suppressing an inhibitory
conformational change (28). In the post-cleavage struc-
ture of the hyperactive Tn5 transpososome the distance be-
tween the C- and N-termini of the subunits is only 12 A˚
(40). To allow ample flexibility for potential conformational
changes at other stages of the reaction we inserted a glycine-
and serine-rich linker of 22 amino acids between the sub-
units. The monomeric and dimeric transposase were puri-
fied (Supplementary Figure S1) and assayed in vitro using
a plasmid substrate (Figure 2B). The reaction yields an ar-
ray of heterogeneous integration products, which are diffi-
cult to quantify (but see Supplementary Figure S2 andRefs.
(32,41) for a description). However, excision of the transpo-
son from the plasmid yields the plasmid backbone, which
is a homogeneous end product of the reaction and a con-
venient measure of the overall efficiency. This is because al-
most all of the excised transposon goes onto complete in-
tegration if incubated long enough. Our first assay was to
titrate the reactionwith themonomeric and the single-chain
dimeric transposases (Figure 2B). Although the reactions
were qualitatively similar, the single-chain dimer appeared
to be slightly less active because a greater amount of the pro-
tein was required to achieve maximum activity. Analysis of
the reaction kinetics, using optimal amounts of each pro-
tein, produced almost identical band patterns. Since these
assays have very little non-specific DNA, we would not ex-
pect to detect any putative advantage that the single-chain
dimer may have in searching for the transposon ends.
Transpososome assembly pathway
Although the activity of the monomer and single-chain
dimer were similar, it is unclear whether the transpososome
assemblymechanism is different. It is possible that assembly
still proceeds via the S-PDmechanismwith one single-chain
dimer at each transposon end (Figure 3A). To address this
issuewemutated one of theDDEmotifs in the active sites of
the single-chain dimer to ADE. In the monomeric protein,
this abolishes the activity (42). This is because the trans-
pososome has inactive subunits at both ends of the trans-
poson. The mutated single-chain dimer yielded a significant
amount of linear plasmid. This is produced by cleavage at
one of the two transposon ends by the one active subunit
in the dimer (Figure 3B). This is consistent with the S-NEC
model for transpososome assembly in which the subunits
in the single-chain dimer are engaged at either end of the
same copy of the transposon. The reactions also produced
a trace amount of plasmid backbone, which requires a func-
tional active site at both ends of the element. We therefore
conclude that although the predominant pathway for trans-
pososome assembly is S-NEC, there may be a low back-
ground level of double-dimer complexes formed. Alterna-
tively, the phenotype of the active site mutation may be
slightly leaky.
To extend the test of the S-NECmodel we introduced the
G462D substitution into one or other of the subunits of the
single-chain dimer. This mutation inhibits the activity of the
monomeric transposase by destabilizing the dimer interface
in the transpososome (43). In the single-chain dimer, the ac-
tivity is abolished when the mutation is introduced into ei-
ther of the subunits (Figure 3B). This is consistent with the
S-NECpathway for transpososome assembly. If the double-
dimer pathway for assemblywas operating, wewould expect
up to 50% activity, which is not observed.
We also compared the binding of the transposase
monomer and single-chain dimer to linear DNA fragments
in an EMSA (Figure 3C). The DNA fragments were of two
different lengths, which we term long end and short end.
When assembled using the short fragment, the transposo-
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pair of panels, the DDE motif, which coordinates the catalytic metal ion in the active site, is changed to ADE by site-directed mutagenesis. This yields
linear plasmid when the single wild-type active site cleaves one of the transposon ends. This is the same result as with the equivalent mutation in an
Hsmar1 transposase single-chain dimer (25). In the second pair of panels, the ability of the protein to dimerize is abolished by the G462D mutation (43).
Photographs of ethidium bromide stained agarose gels are shown. (C) EMSA of the monomeric and single-chain dimeric transposases. Complexes were
assembled using radiolabeled DNA fragments of different lengths. When both DNA fragments are included in the reaction mixture a new transpososome
complex of intermediate mobility appears. This demonstrates that the complex contains a pair of transposon ends. The faint bands between the free DNA
and the PECs is possibly the transposase bound to a single transposon end (L or S +monomer). This could either be present in the original binding reaction
or produced by decay of the PEC during electrophoresis. The gel was recorded on a phosphorimager. *, position of the radioactive label. (D) EMSA of the
cleavage reaction with the indicated transposase derivatives. Binding reactions were as in part C with the shorter of the two DNA fragments.
some complex migrates further down the gel. When long
and short fragments are both included in the reaction, a
mixed complex is detected at an intermediate position. This
demonstrates that the transpososome complex contains a
pair of transposon ends. There was no difference in the
band pattern with transposase monomer and the single-
chain dimer. This suggests that the single-chain dimer is able
to assemble a normal transpososome.
Our final test was to examine the cleavage pattern pro-
duced by themonomer and single-chain dimer transposases
in the EMSA. When the binding reaction is supplemented
with Mg2+, the single-end and double-end cleavage prod-
ucts are detected (Figure 3D). The active site mutations in
the single-chain dimer produced only single-end cleavage
products, which is consistent with the plasmid assays in Fig-
ure 3B. No transpososome complex was detected for the
dimer interface mutant, which is also consistent with the
plasmid assays in Figure 3B. Overall, the behavior of the
single-chain dimer mutants in the plasmid and EMSA as-
says is consistent with the S-NEC pathway for transposo-
some assembly.
The single-chain dimer is hyperactive in bacteria
In our in vitro transposition reactions there is so little non-
specific competitor DNA that the transposon-end interac-
tions are unlikely to limit the rate. If non-specific binding
sites are considered to be 1 bp apart, they are in 2000-fold
excess over transposon ends in a 4 kb substrate plasmid.
However, inE. coli there are three orders ofmagnitudemore
non-specific sites than in the in vitro assay (i.e. 4MB genome
versus 4 kb plasmid). We therefore tested the single-chain
dimer in a bacterial papillation assay (38,44). In this assay,
the mobilization of a promoter-less lacZ transposon is de-
tected as blue spots on the background of a white colony on
X-gal plates (Figure 4). The transposon is on the chromo-
some and the transposase is expressed from a ptac promoter
on a plasmid. In the absence of induction, leaky expression
of the monomeric transposase gives well defined blue spots
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Figure 4. The transposase single-chain dimer is hyperactive in a bacterial
papillation assay. Transposition events during the development of a bacte-
rial colony are revealed as blue spots on a white background, due to mobi-
lization of a promoterless lacZ’ reporter transposon on the chromosome.
The transposases were expressed from a ptac promoter, which is induced by
IPTG. The indicated amounts of IPTG were added to the LB agar plates.
The activity of the single-chain dimer promotes plasmid loss. Cells can be
forced to retain the plasmid if a chloramphenicol selection marker is used.
We do not use the chloramphenicol marker routinely because it stresses the
cells. This becomes noticeable upon prolonged incubation and in experi-
ments when multiple antibiotic markers are present. In one experiment, a
chloramphenicol marker was added to the expression vector to force re-
tention of the plasmid by the cells. Representative colonies are shown. The
entire plates are shown in Supplementary Figure S3.
on a white background. Induction of transposase expres-
sion with IPTG increases the number of spots and produces
a blue-background halo, which is associatedwith a high rate
of transposition.
At the lowest expression level, the single-chain dimer is
much more active than the monomer and produces an al-
most completely blue colony (Figure 4). Full induction of
transposase expression yields a colony morphology typi-
cal of an extremely high rate of transposition. The sec-
tors spreading out toward the edge of the colony are pro-
duced by early transposition events when the colony con-
tains only a handful of cells. The deep blue central spot
and the sectors spreading out toward the edge are caused
by transposition events very early in the development of the
colony (45). Most of the colony is white because the cells
have lost the transposase expression plasmid. This was con-
firmed by the lack of clones recovered after re-streaking on
selective plates, and by performing plasmid mini-preps on
clones recovered from non-selective plates. The reason that
the colony grows even when most of the cells have lost the
plasmid is that the -lactamase diffuses through the plate
and destroys the ampicillin. When we changed the selec-
tive marker on the plasmid to chloramphenicol it prevented
growth of cells that had lost the plasmid, and the colonies
on 1mMIPTGmedia had a uniform coverage of blue papil-
lae (Figure 4). For the Hsmar1 transposase, re-streaking of
the colonies confirmed that the cellsmaintained theHsmar1
transposase expression vector after induction. This is be-
cause Hsmar1 is autoregulated by over-production inhibi-
tion (OPI) (22,38).
OPI was first noted for Mos1 in Drosophila mauritiana
and was subsequently observed in other mariner element
(38,46,47,48). Much later, the phenomenon was explained
as an emergent property of the transposition reaction,
which arose from the multimerization of the transposase
prior to DNA binding (22,35,49). OPI has been demon-
strated for Hsmar1 in HeLa cells and in vitro (22,38). This is
now confirmed by the bacteria papillation assay that shows
that the highest rate of transposition is in the absence of in-
duction (Figure 4). It is therefore noteworthy that the Tn5
single-chain dimer does not behave in this way. Indeed, it
was already clear from the in vitro transposase titration that
the Tn5 single-chain dimer is not inhibited by an 8-fold mo-
lar excess of the protein over transposon ends (Figure 2).
The single-chain dimer is hyperactive in mammalian cells
Themonomeric and single-chain dimeric transposases were
codon optimized and cloned into the pcDNA3.1 expression
vector, which has a strong viral promoter. The transposase
genes had an NLS and a poly-histidine tag (His-tag) added
at the 5′- and 3′-ends, respectively. The level of expression af-
ter transfection intoHeLa cells was assayed bywestern blot-
ting using an anti-His-tag antibody, with His-tagged GFP
cloned in the same vector as a positive control (Figure 5A).
The single-chain dimer was expressed less strongly than the
other two proteins. To determine whether the transposase
was transported to the nucleus, we fused GFP to the trans-
posases and examined the cells by fluorescent microscopy
(Figure 5B). This confirmed that the cells were capable of
transporting the transposase to the nucleus.
To determine the rate of transposition in HeLa cells we
took advantage of a widely-used two-plasmid transfection
assay. One plasmid was the transposase expression vec-
tor, while the other carried a reporter-transposon encod-
ing a neomycin-resistance marker. One day after transfec-
tion, the cells were challenged with G418. Cells in which
the transposon had been integrated into the genome went
on to develop into foci, which were stained with methylene
blue and counted (Figure 5C and D). The number of foci
with the monomeric transposase is about 2-fold above the
background of illegitimate recombination of the reporter
plasmid into the genome. After accounting for the back-
ground, the single-chain dimer is about 7-fold more active
than the monomeric transposase, despite the fact that it was
expressed at a significantly lower level. The transposon in-
tegration was verified by PCR on genomic DNA from two
foci (Figure 5E).
DISCUSSION
Monomeric and dimeric members of the DDE(D) super-
family of transposases appear to use distinct pathways for
assembly of the transpososome (Figure 1A and B). The
dimeric enzymes interact first with one transposon end and
then recruit a second unbound end. The monomeric trans-
posases appear to multimerize only after interacting with
the transposon end sequence (e.g. (26,27,28,29)). All other
things being equal, this type of reaction will be slower be-
cause more components have to come together in one place
at the same time.Multimerization in advance of DNAbind-
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Figure 5. The transposase single-chain dimer is hyperactive in HeLa cells.
(A) HeLa cells were transfected with plasmid expression vectors encod-
ing the indicated His-tagged proteins. Cell extract was western blotted and
probed with an anti-His-tag antibody. (B) A GFPmoiety was added to the
N-terminus of the transposases, which were imaged by fluorescence mi-
croscopy to confirm that the cells could transport the transposases to the
nucleus. (C) A chromosomal integration assay was performed by trans-
fecting cells with the transposase expression vector and a plasmid with
a reporter transposon encoding a neomycin resistance marker. Following
challenge with G418, surviving cells formed foci, which were detected by
methylene blue staining. (D) Foci from part C were counted and plotted.
Error bars are standard error of the mean, n = 8. Ratio paired T-test: **,
P < 0.01; ***, P < 0.0003; ****, P < 0.0001; n = 8. (E) Two integration
events from single-chain dimer transposition reactions in HeLa cells were
mapped by PCR using genomic DNA from the surviving foci after G418
treatment.
ing would therefore appear to be advantageous in searching
for transposon ends in a large genome.
We have explored the effects of transposase multimeriza-
tion by creating a single-chain dimer of the Tn5 transposase
(Figure 2). This had the predicted effect of changing the
pathway of transpososome assembly from S-PD to S-NEC
(Figure 3). This was confirmed by introducing active site
and dimerization mutations into one of the two subunits in
the single-chain dimer (Figure 3B). The strongest evidence
was from the G462D mutant, which disrupts the dimer in-
terface (43). When present in either subunit of the single-
Figure 6. Kinetic diagram of the S-NEC pathway and mechanism of OPI.
The association and dissociation rate constants for transposase binding
are k1 and k-1. Double occupancy of the transposon ends inhibits the re-
action because there are no unbound ends for recruitment into the trans-
pososome. Synapsis (k2) is considered to be irreversible and to represent a
commitment to transposon excision. All subsequent steps of the reaction
can be subsumed into a single rate constant, k3 (22). The relative magni-
tudes of the rate constants for Tn5 and Hsmar1 are summarized below the
diagram. ForTn5, the relative values of k1 and k-1 are unfavorable for OPI.
chain dimer, the mutation abolishes the activity completely
and therefore excludes any residual double-dimer S-PD as-
sembly (Figure 3A). Since the single-chain dimer behaves
normally in the cleavage and EMSA assays, it appears that
the switch from the S-PD to S-NEC pathway does not affect
subsequent steps of the reaction (Figures 2B, 3C and D).
In vivo, the single-chain dimer was hyperactive in the bac-
terial and HeLa cell assays (Figures 4 and 5). Presumably,
the S-NEC pathway increases the frequency at which a pair
of transposon ends will interact with a pair of transposase
subunits. In Hsmar1, a eukaryotic member of the DDE(D)
family, OPI results from the double occupancy of the trans-
poson ends by transposase dimers (Figure 6). This inhibits
the reaction because there are no free ends for recruitment
into the developing transpososome (22). However, the Tn5
single-chain dimer was not subject to OPI in vitro or in the
bacterial assay (Figures 2 and 3).
The absence ofOPI in Tn5 is probably due toweak single-
end binding. Several lines of evidence support the idea that
the association and dissociation rate constants, k1 and k-1,
are unfavorable to OPI (Figure 6). Tn5 transposase has sig-
nificant non-specific DNA binding activity and only a sin-
gle alpha helix that makes sequence-specific interactions in
the major groove of the DNA at the transposon end (40).
The association rate constant, k1, must therefore be rela-
tively low, although it has not been measured. The lack of
extensive sequence-specific interactions also means that the
dissociation rate constant, k-1, must be relatively high. This
is reflected in the fact that little or no single-end complex
is detected in an EMSA with the G462D dimerization mu-
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tant, which prevents assembly of the paired-ends complex
(Figure 3D) (43). The combination of a low value of k1 and
a high value of k-1 are unfavorable for OPI because there
will always be free transposon ends available for recruitment
into the S-NEC pathway (Figure 6).
In contrast to the monomeric bacterial enzymes, the hu-
man Hsmar1 transposase has several properties that en-
hance OPI. The first is that it forms a stable dimer in
the absence of DNA. Subunit exchange experiments esti-
mated t1/2 at about 3 h, which corresponds to a dissocia-
tion rate constant of 6 × 10−5 s−1 (22). This is very sta-
ble; for example, the Cro repressor subunits have a t1/2 of
about 23 s (50). Next, the Hsmar1 transposase has a low
affinity for non-specific DNA and two helix-turn-helix do-
mains for sequence-specific binding (22,32,51). This means
that the value of k1 will be high compared to Tn5 trans-
posase. Single-end binding in Hsmar1 is further increased
by an unusually long dwell time (low k-1), which we es-
timated at about 10 min. This is also very stable; typical
helix-turn-helix proteins have dwell times of <1 min (22).
Finally, single-end binding is accompanied by a conforma-
tional change that sharply reduces the affinity of the second
transposase monomer for the second transposon end. This
equates to a lower than expected value for the association
rate constant k2. Together, these factors enhance OPI and
provide Hsmar1 with a mechanism for autoregulation.
Are there any other ways in which Tn5 transposition
could be improved in the large genome of a eukaryotic
cell? One approach would be to fuse the single-chain dimer
to a strong DNA-binding domain and to add its cognate
binding-site next to the transposon end. This would boost
k1App. and reduce k-1App. by tethering the transposase close
to the transposon end.
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